CVE-2026-111855: Tektronix 3 Series MDO · Path Traversal
Affects Tektronix 3 Series MDOSource CVE Database V5
Not known to be exploited · CVSS 7.5 High : upgrade to 1.21.1 soon.
Data as of 26 Oct 2026, 14:18 UTC
- EPSS
- 0.6% chance of exploitation in 30 days – higher than 48% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in 1.21.1
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:NExploitation evidence
Disclosed: evidence found.
CVE published 17 Oct 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Upgrade Tektronix 3 Series MDO to 1.21.1.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Tektronix3 Series MDO | Affected
| Fixed in
|
AI-suggested
A fix is available in Tektronix 3 Series MDO version 1.21.1 or later. Users should upgrade to version 1.21.1 or newer to remediate this vulnerability. No vendor advisory content is provided to indicate alternative mitigations or temporary fixes. Until patched, restricting network access to the web management interface and monitoring for unauthorized access attempts may reduce exposure.
Description
Tektronix 3 Series MDO devices before version 1.21.1 contain a path traversal vulnerability in their web management interface. This flaw allows remote attackers to read arbitrary files accessible to the application by exploiting insufficient validation of user-supplied file paths. Exploitation may be possible without authentication depending on the device configuration. The vulnerability has a high severity rating with a CVSS score of 7.5.